Simplex Trading, LLC Uro Gen Pharma Ltd. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$12.7 - $17.92 $106,832 - $150,743	8,412 Added 79.22%	19,031 $241,000
Q2 2024 Jul 25, 2024	BUY	$12.72 - $19.2 $99,394 - $150,028	7,814 Added 278.57%	10,619 $178,000
Q1 2024 Apr 25, 2024	SELL	$13.81 - $19.33 $53,113 - $74,343	-3,846 Reduced 57.83%	2,805 $42,000
Q4 2023 Feb 02, 2024	BUY	$10.87 - $15.93 $38,055 - $55,770	3,501 Added 111.14%	6,651 $99,000
Q3 2023 Nov 01, 2023	SELL	$8.84 - $22.64 $275,710 - $706,118	-31,189 Reduced 90.83%	3,150 $44,000
Q2 2023 Aug 04, 2023	SELL	$8.75 - $14.29 $5,442 - $8,888	-622 Reduced 1.78%	34,339 $355,000
Q1 2023 Apr 27, 2023	BUY	$7.99 - $11.02 $252,971 - $348,904	31,661 Added 959.42%	34,961 $323,000
Q4 2022 Feb 02, 2023	SELL	$7.55 - $11.96 $4,114 - $6,518	-545 Reduced 14.17%	3,300 $29,000
Q3 2022 Nov 04, 2022	BUY	$7.21 - $9.41 $26,857 - $35,052	3,725 Added 3104.17%	3,845 $31,000
Q2 2022 Aug 03, 2022	SELL	$5.12 - $8.74 $849 - $1,450	-166 Reduced 58.04%	120 $0
Q1 2022 May 02, 2022	BUY	$5.92 - $9.73 $515 - $846	87 Added 43.72%	286 $2,000
Q4 2021 Feb 23, 2022	BUY	$9.03 - $19.13 $1,715 - $3,634	190 Added 2111.11%	199 $1,000
Q2 2021 Aug 12, 2021	SELL	$15.2 - $20.94 $5,350 - $7,370	-352 Reduced 97.51%	9 $0
Q1 2021 Apr 26, 2021	BUY	$17.99 - $26.96 $1,349 - $2,022	75 Added 26.22%	361 $7,000
Q4 2020 Feb 02, 2021	BUY	$17.54 - $25.43 $5,016 - $7,272	286 New	286 $5,000
Q1 2020 Apr 29, 2020	SELL	$13.68 - $34.6 $167,744 - $424,265	-12,262 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$21.11 - $34.86 $116,189 - $191,869	5,504 Added 81.44%	12,262 $409,000
Q3 2019 Oct 15, 2019	BUY	$23.83 - $36.44 $161,043 - $246,261	6,758 New	6,758 $161,000

Others Institutions Holding URGN

# of Institutions

132

Shares Held

36M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $241M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account